Explore 1M+ Live Opportunities.
Direct applications, high-package MNC listings, and exclusive insider referrals updated daily across 50+ niches worldwide.
Direct applications, high-package MNC listings, and exclusive insider referrals updated daily across 50+ niches worldwide.
Caristo Diagnostics · Oxford, England, United Kingdom
A fantastic opportunity has become available for a Quantitative Imaging Scientist to join Caristo Diagnostics rapidly growing team, based at our Oxford headquarters.
Caristo's technology depends on the accurate and reliable quantitative assessment of cardiac CT scans. This role owns the calibration capability that underpins both our current clinical services and the next generation of our AI-driven cardiovascular products.
You will join a small, highly collaborative Product Innovation team working at the interface between research, engineering, operations and clinical delivery. The role combines scientific thinking with practical execution and requires someone who can make good decisions despite incomplete information, competing priorities and changing requirements.
Success in this role is measured by keeping critical programmes moving, enabling clinical delivery, supporting product development and helping the company make pragmatic technical decisions.
This is an ideal role for someone who enjoys solving real-world problems, working across teams and turning ambiguity into action.
What You'll Be Doing
Calibration Ownership
With the first and only FDA approved (July 29, 2026) coronary artery inflammation diagnostic medical device, CaRi-Heart®, Caristo Diagnostics is a global leader in AI technologies for cardiovascular disease, founded as a spin-out from the University of Oxford in 2018. Caristo also has an FDA approved (2025) coronary artery plaque diagnostic medical device. Its award-winning inflammation technology helps detect hidden heart disease and identify people at risk of a heart attack before symptoms appear allowing for proactive disease management. Working with leading hospitals, research institutions, and pharmaceutical partners, Caristo aims to save lives through early detection and personalized prevention. The company was named a 2026 Technology Pioneer by the World Economic Forum in June 2026. Learn more at
or follow Caristo on LinkedIn, YouTube, and X.
About the CaRi-Heart® Technology
Named first of “7 Technologies That Could Change Heart Healthcare Forevermore” by the Robb Report, the CaRi-Heart® technology is Caristo’s flagship offering which uncovers hidden coronary inflammation, a key driver of cardiovascular disease, on routine Coronary Computed Tomography Angiography (CCTA).
The technology is regulatory approved for clinical use in US, UK, Europe, and Australia and is in use with a growing number of hospitals and clinics. Multiple patents underpinning CaRi-Heart technologies have been granted in major jurisdictions around the world. In addition, exceptional validation results showing CaRi-Heart’s ability to aid the prediction of heart attacks have been published in leading medical journals including the Lancet, JACC, European Heart Journal, and Cardiovascular Research.
Job Title Research Quantitative Imaging Scientist/ Platform Engineer
Department Head of Research and Innovation
Location Oxford, UK (full time in-office)
Details
| Company | Caristo Diagnostics |
| Location | Oxford, England, United Kingdom |
| Type | FULL TIME |
| Niche | tech |